Skip to main content
Livermore
Livermore
ZHEN

Northern Trust Corp

SEC CIK
0000073124
Latest filing
Aug 13, 2026

APLS holding history

Apellis Pharmaceuticals, Inc. in every 13F filed by Northern Trust Corp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

APLS overviewAll 13F holders of APLSFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of APLS by Northern Trust Corp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−738,440−100.0%Sold outHolders
Q1 2026738,440$29.7M<0.1%+41,919+6.0%AddedHolders
Q4 2025696,521$17.5M<0.1%+147,273+26.8%AddedHolders
Q3 2025549,248$12.4M<0.1%+23,366+4.4%AddedHolders
Q2 2025525,882$9.10M<0.1%+7,188+1.4%AddedHolders
Q1 2025518,694$11.3M<0.1%−28,582−5.2%ReducedHolders
Q4 2024547,276$17.5M<0.1%+94,174+20.8%AddedHolders
Q3 2024453,102$13.1M<0.1%−9,116−2.0%ReducedHolders
Q2 2024462,218$17.7M<0.1%+21,762+4.9%AddedHolders
Q1 2024440,456$25.9M<0.1%−8,270−1.8%ReducedHolders
Q4 2023448,726$26.9M<0.1%−1,704−0.4%ReducedHolders
Q3 2023450,430$17.1M<0.1%−401,842−47.1%ReducedHolders
Q2 2023852,272$77.6M<0.1%−16,916−1.9%ReducedHolders
Q1 2023869,188$57.3M<0.1%+12,067+1.4%AddedHolders
Q4 2022857,121$44.3M<0.1%+7,933+0.9%AddedHolders
Q3 2022849,188$58.0M<0.1%+16,490+2.0%AddedHolders
Q2 2022832,698$37.7M<0.1%+67,496+8.8%AddedHolders
Q1 2022765,202$38.9M<0.1%+21,335+2.9%AddedHolders
Q4 2021743,867$35.2M<0.1%+81,181+12.3%AddedHolders
Q3 2021662,686$21.8M<0.1%−11,811−1.8%ReducedHolders
Q2 2021674,497$42.6M<0.1%+10,173+1.5%AddedHolders
Q1 2021664,324$28.5M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.